Letter to the Editor

Vol.2, No.3, 73-73 (2013) Advances in Alzheimer ’s Disease

http://dx.doi.org/10.4236/aad.2013.23010

Lin Shi

Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Hong Kong, China;

shilin@cuhk.edu.hk

Received 10 June 2013; revised 20 June 2013; accepted 27 July 2013

unrestricted use, distributi on, and reproduction in any medium, provided the original work is properly cited.

Dear Editor

Alzheimer’s Disease (AD) is the most common type

of dementia. It causes an impact of caregiving on care-

givers, on economy of a society, and cost and demand of

a health care system. According to the report in 2011

from Alzheimer’s Association, approximately 13 percent

of people aged 65 or older have AD in the United States.

Study in AD is one of the fastest growing interests in the

field of dementia and gerontology. The scientific study

of AD has grown rapidly in the last two decades from

2095 publications in 1992 to 4960 in 2002 and 9882 in

2012 by searching the keyword “Alzheimer” in Scopus.

The number of publications doubles every decade but the

number of journals that focus on AD research and de-

mentia is very limited. To meet the fast growing and ad-

vanced technologies in pathogenesis, diagnosis and prog-

nosis of AD, a comprehensive and periodical platform

will satisfy the need to provide unique and updated in-

formation in this field. Advances in Alzheimer’s Disease

(AAD) is a new quarterly scientific journal to share and

discuss new issues, findings and advanced developments

in AD.

The scopes of AAD include but are not limited to an-

imal models, etiology, epidemiology, genetics, patho-

genesis, diagnosis, therapeutic development and behave-

ioral study of AD. It accepts original articles, short re-

ports that present theoretical ideas and book reviews. Our

goal is to present high quality of manuscripts and allow

easy access for researchers to collect valuable information.

In AD research, studies may involve genetic experi-

ment, pathogenesis, neurological changes, therapeutics

evaluation, medical imaging, biological changes etc. The

editorial board is composed of researchers and specialists

with a broad range of interests in Molecular Biology,

Genetics, Pathology, Neurological Sciences, Medicine,

Computer Science, Pharmacy, Biochemistry etc. from

different counties and regions over the world. We are

committed to the highest quality of scientific research on

AD. With a team of members from multidiscipline, our

goal is to conduct AD research from different approaches

such as in radiology, psychiatry, neurology, computer

science and medical engineering. I believe this platform

will attract submissions of manuscripts with good stan-

dard and quality o f scien tific collections in AD research.

上一篇:Longitudinal Follow-Up of a Po 下一篇:Advances in Alzheimer’s disea

我要分享到：

职称论文发表交流平台！

Letter to the Editor

最新文章NEWS

推荐期刊Tui Jian

热点文章HOT